Prelude Therapeutics, Inc. (PRLD)
4.53
-0.17
(-3.62%)
USD |
NASDAQ |
Apr 27, 16:00
4.64
+0.11
(+2.43%)
After-Hours: 18:14
Prelude Therapeutics EPS Diluted (Quarterly) : -0.2614 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Incyte Corp. | 1.462 |
| Niagen Bioscience, Inc. | 0.0489 |
| Immunome, Inc. | -0.7516 |
| Sana Biotechnology, Inc. | -0.2132 |
| Moderna, Inc. | -2.107 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.46M |
| Revenue (Quarterly) | 5.64M |
| Total Expenses (Quarterly) | 22.10M |
| Enterprise Value | 210.69M |
| Gross Profit Margin (Quarterly) | 92.59% |
| Profit Margin (Quarterly) | -291.8% |
| Earnings Yield | -29.88% |
| Normalized Earnings Yield | -29.88 |